Plazza in Talks to Raise $15 Million from Accel, Nexus, Elevation to Scale Quick Medicine Delivery
Barely six months after raising its seed round, Bengaluru-based quick medicine delivery startup Plazza is already back at the negotiating table with some of India’s most prominent venture capital firms.
The company is in advanced talks to raise $12-15 million in a new funding round led by Accel, Nexus Venture Partners, and Elevation Capital . The round would value the startup at approximately $45-50 million, marking a significant step up from its September 2025 seed round of $1.4 million .
Existing backers All In Capital and Better Capital are also expected to participate in the round .
The rapid follow-on raise signals strong early traction for Plazza’s model, but it also underscores the capital-intensive nature of the quick commerce pharmacy business, which relies on owning inventory and running hyperlocal fulfilment infrastructure .
The Model: Omnichannel Pharmacy with a Speed Promise
Founded in 2024 by Aman Priyadarshi, a former senior Zomato executive, Plazza is positioning itself at the intersection of two high-growth sectors: quick commerce and healthcare .
Core Features of Plazza’s Model:
Unlike traditional e-pharmacies that operate purely online, Plazza has adopted an omnichannel approach. It currently operates two physical outlets in Bengaluru and plans to scale this to around 20 stores by the end of the year . These stores function similarly to dark stores used by grocery delivery platforms, stocking a wide range of medicines and healthcare products for hyperlocal fulfilment .
The company’s physical footprint serves a dual purpose: it enables rapid delivery while also allowing customers to walk in and purchase directly—a feature that builds trust in a category where reliability is paramount .
Beyond Prescription Medicines: Expanding the Assortment
Plazza is not limiting itself to prescription drugs. The startup is building a wider assortment across categories, positioning itself as a comprehensive healthcare and wellness destination .
Expansion Categories:
| Category | Status |
|---|---|
| Prescription Medicines | Core offering |
| Ayurvedic Products | Already selling |
| Beauty & Personal Care | Already selling |
| Healthy Snacks | Planned |
| Mother & Baby Care | Planned |
| Elder Care | Planned |
| Dermatology Products | Planned |
A typical pharmacy stocks 4,000-5,000 SKUs. Plazza, by contrast, offers over 20,000 SKUs—significantly higher than a neighbourhood pharmacy—giving customers access to a much wider range of medicines and healthcare products .
The Franchise Model: “Lifestores”
One of Plazza’s distinctive features is its franchise model, which it calls “Lifestores” . Rather than relying entirely on dark stores, Plazza partners with existing pharmacies to convert them into Plazza-run outlets.
What Plazza Provides to Partner Stores:
- Inventory management support
- Software installation and integration
- Staff hiring assistance
- Customer acquisition through its platform
In exchange, Plazza splits profits with partner stores . This approach addresses a key challenge in the pharmacy sector: limited control over service quality. By bringing partner stores into its ecosystem, Plazza can ensure consistent delivery standards across its network .
The approach draws on co-founder Aniruddha Sen’s earlier experience at Kenko Health, where he saw how limited control over service quality held back growth . (Sen has since moved on to launch an AI-powered legal tech startup, Miss Lucy .)
Early Traction: 50,000 Customers and Counting
Plazza has shown promising growth metrics in a short period. The company has now served around 50,000 customers, up from approximately 10,000 as of September 2025 . Weekly growth has been pegged at around 25 percent .
The average order value is reported to be around ₹700 . With 20,000 SKUs and a growing customer base, Plazza is building a defensible position in a market where speed, assortment, and trust are critical differentiators.
The Competitive Landscape: A Crowded and Growing Market
Plazza is entering a space that is rapidly heating up. Quick commerce platforms are increasingly pushing 10-15 minute delivery of over-the-counter medicines and supplements .
Key Competitors in Quick Pharma Delivery:
| Player | Approach |
|---|---|
| Swiggy Instamart | Partnership with PharmEasy |
| Zepto | In-house delivery of OTC medicines |
| Amazon India | Partnered with Orange Health for diagnostics |
| Tata 1mg | Traditional e-pharmacy with quick delivery options |
| Apollo Pharmacy | Legacy pharmacy chain with online presence |
Plazza’s differentiation lies in its omnichannel, inventory-led model. By owning physical stores and stocking a wider range of products than a typical pharmacy, the startup aims to offer both speed and comprehensiveness .
The broader quick commerce market in India is poised to grow from $6.1 billion in 2024 to $40 billion by 2030, clocking a CAGR of 37%—nearly twice the 19% growth rate of the overall e-commerce industry . Pharmacy delivery is a critical sub-segment of this growth story.
Why Investors Are Betting on Quick Pharmacy
The interest from top-tier firms like Accel, Nexus, and Elevation Capital reflects a broader thesis about the convergence of quick commerce and healthcare.
Investment Thesis Drivers:
- Recurring Demand: Medicines are an essential, non-discretionary category with predictable repurchase cycles.
- Trust Advantage: An omnichannel presence (physical stores + app) builds consumer trust in a way that pure-play online pharmacies cannot.
- Quick Commerce Infrastructure: The dark store model, proven in grocery, is now being applied to pharmacy—with the added advantage of higher average order values.
- Regulated Category: While this presents barriers to entry, it also creates moats for established players who navigate compliance effectively.
- Urban Convenience: In congested cities, the ability to receive medicines within 15-60 minutes is a powerful value proposition for time-pressed consumers.
The proposed investment comes at a time when venture capital firms are doubling down on startups offering rapid delivery across categories, including instant house-help platform Snabbit and construction materials delivery startup Homerun .
The Use of Funds: From Two Stores to Twenty
With the fresh capital, Plazza has a clear and aggressive expansion roadmap:
The rapid expansion plan reflects the capital intensity of the inventory-led quick commerce model. Unlike asset-light marketplace models, Plazza must invest in physical infrastructure, inventory, and supply chain capabilities to deliver on its speed promise .
What This Means for India’s Healthtech Ecosystem
Plazza’s funding talks carry several important signals for India’s startup landscape:
1. Quick Commerce Is Coming to Healthcare
The success of 10-15 minute delivery in grocery is now being replicated in pharmacy. This represents a significant shift in consumer expectations around healthcare access.
2. Trust Requires Physical Presence
Unlike grocery, where pure-play online models have thrived, pharmacy delivery may require an omnichannel approach. The ability to walk into a physical store builds trust in a category where authenticity and reliability are critical.
3. The Battle for Last-Mile Healthcare Is Intensifying
With Swiggy, Zepto, Amazon, and now dedicated startups like Plazza entering the space, last-mile healthcare delivery is becoming a fiercely contested category.
4. Capital Intensity Is a Feature, Not a Bug
The inventory-led quick commerce model requires significant capital to scale. This creates barriers to entry that can protect incumbents who raise sufficient funding.
5. The “Pharmacy as a Platform” Opportunity
Beyond medicines, Plazza’s expansion into mother and baby care, elder care, dermatology, and healthy snacks suggests that pharmacies can become comprehensive wellness platforms—not just places to buy medicines.
The Road Ahead
The proposed $12-15 million round would be Plazza’s second in less than a year, following its September 2025 seed round of $1.4 million led by All In Capital . The rapid follow-on raise signals both strong early traction and the capital demands of the model.
If the round closes as expected, Plazza will have the resources to:
- Expand its store network from 2 to approximately 20 locations in Bengaluru
- Deepen its inventory across prescription and non-prescription categories
- Strengthen its supply chain and fulfilment capabilities
- Build brand awareness and acquire customers in a competitive market
The startup’s average order value of approximately ₹700 provides a solid foundation for unit economics, but the path to profitability will require careful management of customer acquisition costs and operational efficiency .
With competition heating up from Swiggy Instamart, Zepto, and Amazon India, Plazza is betting on speed, assortment, and reliability to stand out in the e-pharmacy race .
The Final Word
Plazza’s advanced talks to raise $12-15 million from Accel, Nexus Venture Partners, and Elevation Capital represent a significant moment for India’s quick commerce pharmacy sector. The startup’s omnichannel, inventory-led model—combining physical stores with rapid delivery—offers a differentiated approach to a category where trust and speed are equally important.
With a founder who brings experience from Zomato’s hypergrowth days, a growing customer base of 50,000 users, and ambitious plans to scale from 2 to 20 stores by year-end, Plazza is positioning itself as a serious contender in the race to redefine last-mile healthcare delivery in India.
As quick commerce expands beyond grocery into essential categories like pharmacy, the startups that can balance speed with reliability—and capital intensity with operational efficiency—will emerge as the category leaders. Plazza is making its case to be one of them.
